ZymoGenetics


PIPELINE OVERVIEW | PIPELINE | RECOTHROM®
OUTLICENSED PRODUCTS | CANDIDATE BACKGROUNDERS

 
 
Select Program: 
Select Indication: 
R & D
Pre-Clinical IND
CLINICAL
Phase 1 Phase 2 Phase 3 Pre-Registration
POST-APPROVAL
Registration Marketed
Therapeutic Candidate Target Indication
RECOTHROM Surgical Hemostasis 
Marketed
IL-21 Metastatic Melanoma 
Phase 2
IL-21 & Nexavar Renal Cell Carcinoma 
Phase 2
IL-21 & Rituxan Non-Hodgkin's Lymphoma 
Phase 1
PEG-Interferon lambda Hepatitis C 
Phase 1


Back to top.Back to top

Home Site Map Contact Terms & Conditions Glossary
copyright © 2003 - 2008 ZymoGenetics